AMR: Antimicrobial Resistance

What we do > Lebanon Office Activities > AMR: Antimicrobial Resistance

Antimicrobial resistance (AMR) poses a significant global health threat, with far-reaching consequences for public health, food security, and development. The Middle East and North Africa (MENA) region is particularly vulnerable, experiencing some of the highest increases in antibiotic consumption worldwide. In North Africa and the Middle East alone, AMR is responsible for approximately 68,300 deaths annually.

Antimicrobial resistance (AMR) occurs when microorganisms such as bacteria, viruses, fungi, and parasites evolve to withstand the effects of medications that once effectively treated infections caused by these organisms. This resistance makes it increasingly difficult to manage infections, leading to longer illness durations, higher healthcare costs, and increased mortality

MSF is committed to combating AMR through a comprehensive, multi-layered approach. This includes advocating for policy changes, raising public awareness about the impact of AMR, promoting the responsible use of antibiotics, and providing guidance to prevent the spread of infectious diseases.

MSF has witnessed the growing impact of antimicrobial resistance (AMR) on patients, providers, and communities. Given its potential to undermine the very foundation of healthcare and inflict human and economic damage on a grand scale. Addressing AMR and averting its most catastrophic outcomes should be a priority across the world.

MSF is tackling the spread of #AMR through various approaches, such as implementing multidisciplinary actions in our health facilities and advocating for change with relevant stakeholders.

Play